ArticleFrontiers in oncology2023

Monoclonal antibodies binding to different epitopes of CD20 differentially sensitize DLBCL to different classes of chemotherapy.

Brian Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.